Bio-Rad Laboratories Inc

BIONYSE · USD
358.90USD0.00 (-2.34%)
769

Bio-Rad Laboratories Inc (BIO) Covered Calls

Bio-Rad Laboratories Inc trades in the Medical Devices industry with an IV Rank of 39.09%, average versus the past year. BIO's highest covered call setup is the $390.00 strike expiring Nov 20, 2026, sorted by theoretical annualized return. It's 6.45% out of the money with 7 days to expiration, a 6.48% return until expiration, and a 337.88% theoretical annualized return. Across the setups shown, annualized returns run from 102.10% to 337.88% at strikes between $370.00 and $580.00, with 7 to 189 days to expiration, as of Nov 13, 2026.

Read more

Running BIO covered calls helps you generate income from Bio-Rad Laboratories Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best BIO covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If BIO stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling BIO covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given BIO covered call is worth writing.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety.

2026-11-207390.006.450.1010.002374.006.48337.88-0.03+0.26139.90
2026-11-207380.003.720.1010.001374.003.75195.56-0.03+0.3249.90
2026-12-1835430.0017.370.0510.006369.0017.38181.30-0.01+0.1809.95
2026-12-1835420.0014.640.0510.005369.0014.65152.83-0.01+0.1929.95
2026-12-1835410.0011.910.1010.004374.0011.94124.51-0.03+0.2139.90
2026-11-207370.000.994.908.90854.002.33121.55-1.34+0.4504.00
2027-03-19126520.0041.940.0510.0015369.0041.95121.52-0.01+0.1209.95
2027-05-21189580.0058.310.0510.0021369.0058.33112.64-0.01+0.1009.95
2027-03-19126500.0036.480.0510.0013369.0036.49105.71-0.01+0.1319.95
2027-05-21189560.0052.860.0510.0019369.0052.87102.10-0.01+0.1109.95

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV Rank39.09% Moderate
  • Market cap (M$)9,693
  • 52 weeks high-9.42%
  • 52 weeks low51.61%
  • Analyst recommendationHold
    3.00
  • Target price$395.00
    10.06% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2027-02-11
  • P/E9.45
  • Future P/E34.23
  • EPS (ttm)37.97
  • EPS growth next 5 years6.18%

As of Nov 20, 2026